InvestorsHub Logo
Followers 13
Posts 614
Boards Moderated 0
Alias Born 04/10/2013

Re: None

Thursday, 06/22/2017 2:46:59 PM

Thursday, June 22, 2017 2:46:59 PM

Post# of 54978
In November 2014 Henry said the company has "reaffirmed their commitment to X-22". Does anyone have a good answer why it took them nearly 3 years to have a meeting with the FDA to discuss P3 trials?

I'm assuming we have at least 2 years from now before any type of approval action happens. So 5+ years since the company recommitted to X-22? Is that at all acceptable to anyone? Anyone have a good reason why?

I'm still very long and very bullish here. I'm just incredibly frustrated how long it has taken to develop a clear path forward with X-22. X-22 is such an incredible product...it's sad the public can't make use of it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News